Literature DB >> 26214527

Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction.

Geoffrey de Couto, Weixin Liu, Eleni Tseliou, Baiming Sun, Nupur Makkar, Hideaki Kanazawa, Moshe Arditi, Eduardo Marbán.   

Abstract

Ischemic injury in the heart induces an inflammatory cascade that both repairs damage and exacerbates scar tissue formation. Cardiosphere-derived cells (CDCs) are a stem-like population that is derived ex vivo from cardiac biopsies; they confer both cardioprotection and regeneration in acute myocardial infarction (MI). While the regenerative effects of CDCs in chronic settings have been studied extensively, little is known about how CDCs confer the cardioprotective process known as cellular postconditioning. Here, we used an in vivo rat model of ischemia/reperfusion (IR) injury-induced MI and in vitro coculture assays to investigate how CDCs protect stressed cardiomyocytes. Compared with control animals, animals that received CDCs 20 minutes after IR had reduced infarct size when measured at 48 hours. CDCs modified the myocardial leukocyte population after ischemic injury. Specifically, introduction of CDCs reduced the number of CD68+ macrophages, and these CDCs secreted factors that polarized macrophages toward a distinctive cardioprotective phenotype that was not M1 or M2. Systemic depletion of macrophages with clodronate abolished CDC-mediated cardioprotection. Using both in vitro coculture assays and a rat model of adoptive transfer after IR, we determined that CDC-conditioned macrophages attenuated cardiomyocyte apoptosis and reduced infarct size, thereby recapitulating the beneficial effects of CDC therapy. Together, our data indicate that CDCs limit acute injury by polarizing an effector macrophage population within the heart.

Entities:  

Mesh:

Year:  2015        PMID: 26214527      PMCID: PMC4563759          DOI: 10.1172/JCI81321

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  76 in total

1.  IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium.

Authors:  Amit Saxena; Wei Chen; Ya Su; Vikrant Rai; Olisambu U Uche; Na Li; Nikolaos G Frangogiannis
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

2.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.

Authors:  Lei Ye; Ying-Hua Chang; Qiang Xiong; Pengyuan Zhang; Liying Zhang; Porur Somasundaram; Mike Lepley; Cory Swingen; Liping Su; Jacqueline S Wendel; Jing Guo; Albert Jang; Daniel Rosenbush; Lucas Greder; James R Dutton; Jianhua Zhang; Timothy J Kamp; Dan S Kaufman; Ying Ge; Jianyi Zhang
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

3.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

4.  Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation.

Authors:  Slava Epelman; Kory J Lavine; Anna E Beaudin; Dorothy K Sojka; Javier A Carrero; Boris Calderon; Thaddeus Brija; Emmanuel L Gautier; Stoyan Ivanov; Ansuman T Satpathy; Joel D Schilling; Reto Schwendener; Ismail Sergin; Babak Razani; E Camilla Forsberg; Wayne M Yokoyama; Emil R Unanue; Marco Colonna; Gwendalyn J Randolph; Douglas L Mann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

5.  Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction.

Authors:  Konstantinos Malliaras; Rachel R Smith; Hideaki Kanazawa; Kristine Yee; Jeffrey Seinfeld; Eleni Tseliou; James F Dawkins; Michelle Kreke; Ke Cheng; Daniel Luthringer; Chak-Sum Ho; Agnieszka Blusztajn; Ileana Valle; Supurna Chowdhury; Raj R Makkar; Rohan Dharmakumar; Debiao Li; Linda Marbán; Eduardo Marbán
Journal:  Circulation       Date:  2013-09-23       Impact factor: 29.690

Review 6.  Patching the heart: cardiac repair from within and outside.

Authors:  Lei Ye; Wolfram-Hubertus Zimmermann; Daniel J Garry; Jianyi Zhang
Journal:  Circ Res       Date:  2013-09-13       Impact factor: 17.367

Review 7.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

8.  Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation post-infarction by intramyocardially-injected cardiospheres.

Authors:  Eleni Tseliou; Geoffrey de Couto; John Terrovitis; Baiming Sun; Liu Weixin; Linda Marbán; Eduardo Marbán
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

9.  Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction.

Authors:  Konstantinos Malliaras; Ahmed Ibrahim; Eleni Tseliou; Weixin Liu; Baiming Sun; Ryan C Middleton; Jeffrey Seinfeld; Lai Wang; Behrooz G Sharifi; Eduardo Marbán
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

10.  Exosomes as critical agents of cardiac regeneration triggered by cell therapy.

Authors:  Ahmed Gamal-Eldin Ibrahim; Ke Cheng; Eduardo Marbán
Journal:  Stem Cell Reports       Date:  2014-05-08       Impact factor: 7.765

View more
  95 in total

1.  Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

2.  Macrophages in the Remodeling Failing Heart.

Authors:  Bijun Chen; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-09-16       Impact factor: 17.367

3.  Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.

Authors:  Romain Gallet; James Dawkins; Jackelyn Valle; Eli Simsolo; Geoffrey de Couto; Ryan Middleton; Eleni Tseliou; Daniel Luthringer; Michelle Kreke; Rachel R Smith; Linda Marbán; Bijan Ghaleh; Eduardo Marbán
Journal:  Eur Heart J       Date:  2017-01-14       Impact factor: 29.983

Review 4.  Exosomal therapy-a new frontier in regenerative medicine.

Authors:  Sathish Muthu; Asawari Bapat; Rashmi Jain; Naveen Jeyaraman; Madhan Jeyaraman
Journal:  Stem Cell Investig       Date:  2021-04-02

Review 5.  Macrophage-based therapeutic strategies in regenerative medicine.

Authors:  Kara L Spiller; Timothy J Koh
Journal:  Adv Drug Deliv Rev       Date:  2017-05-16       Impact factor: 15.470

Review 6.  The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy.

Authors:  Francesca Pagano; Vittorio Picchio; Francesco Angelini; Alessandra Iaccarino; Mariangela Peruzzi; Elena Cavarretta; Giuseppe Biondi-Zoccai; Sebastiano Sciarretta; Elena De Falco; Isotta Chimenti; Giacomo Frati
Journal:  Curr Cardiol Rep       Date:  2018-08-13       Impact factor: 2.931

Review 7.  Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction.

Authors:  Matthew DeBerge; Sanjiv J Shah; Lisa Wilsbacher; Edward B Thorp
Journal:  Trends Mol Med       Date:  2019-02-05       Impact factor: 11.951

8.  Cell biological mechanisms in regulation of the post-infarction inflammatory response.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Opin Physiol       Date:  2017-12-13

9.  IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation.

Authors:  Mira Jung; Yonggang Ma; Rugmani Padmanabhan Iyer; Kristine Y DeLeon-Pennell; Andriy Yabluchanskiy; Michael R Garrett; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2017-04-24       Impact factor: 17.165

Review 10.  Monocyte and macrophage contributions to cardiac remodeling.

Authors:  Maarten Hulsmans; Flora Sam; Matthias Nahrendorf
Journal:  J Mol Cell Cardiol       Date:  2015-11-21       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.